Evaluation of the pharmaceuticals industry investment program

Submissions

Submissions

* Submissions marked with an asterisk have omitted 'In confidence' content - part or all of the submission is not online.

# Hash denotes some attachments are not available online. Contact the project team for access if necessary.

% Percent symbol denotes scanned image PDFs which are not readable by some screen readers. For help read our accessibility statement.

Copyright in submissions resides with the author(s), not with the Productivity Commission.

All submissions will remain on the Commission's website indefinitely.


No.Individual / OrganisationDatePagesFile/s
1
Association of Australian Medical Research Institutes
16/09/20022
2
Merck Sharp & Dohme (Australia) Pty Limited
14/10/20029
3
Department of Innovation, Industry and Regional Development
04/11/200225
4
Mayne Pharma *
06/11/200223  
8
Industry Tourism Resources
15/01/20039
9
Eli Lilly Australia Pty Limited
15/01/200320
10
Medicines Australia
15/01/200349
11
Merck Sharp & Dohme
16/01/200337
12
Pfizer
30/01/200337
13
CSL limited
16/01/20032
14
Ausbiotech
16/01/20038
15
Victoria University
17/01/200315
16
Department of State and Regional Development
17/01/20035
17
Bristol-Myers Squibb Australia Pty Ltd *
20/01/200322  
18
ARI (ANSTO)
30/01/20033